Natural Product: NPC303658

Natural Product IDNPC303658
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
Tryprostatin A
IUPAC Name (3S,8aS)-3-[[6-methoxy-2-(3-methylbut-2-enyl)-1H-indol-3-yl]methyl]-2,3,6,7,8,8a-hexahydropyrrolo[1,2-a]pyrazine-1,4-dione
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL289159
PubChem CID 9929833
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000264] Organic acids and derivatives
      • [CHEMONTID:0000265] Carboxylic acids and derivatives
        • [CHEMONTID:0000013] Amino acids, peptides, and analogues
          • [CHEMONTID:0000347] Amino acids and derivatives
            • [CHEMONTID:0000060] Alpha amino acids and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey XNRPVPHNDQHWLJ-PMACEKPBSA-N
Standard InCHI InChI=1S/C22H27N3O3/c1-13(2)6-9-17-16(15-8-7-14(28-3)11-18(15)23-17)12-19-22(27)25-10-4-5-20(25)21(26)24-19/h6-8,11,19-20,23H,4-5,9-10,12H2,1-3H3,(H,24,26)/t19-,20-/m0/s1
SMILES COc1ccc2c(c1)[nH]c(c2C[C@@H]1N=C(O)[C@H]2N(C1=O)CCC2)CC=C(C)C

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   381.21 Volume:   395.748
?
Van der Waals volume.
Dense:   0.963 LogP:   3.478
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   2.961
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.932
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   5.0 Rigid Bonds:   22.0
TPSA:   77.92
?
Topological Polar Surface Area.
H-Bond Acceptor:   6.0
H-Bond Donor:   2.0 Rings:   4.0
Heavy Atoms:   6.0

MedChem Properties

QED Drug-Likeness Score:   0.778 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   3.925 Fsp3:   0.455
MCE-18:   76.188
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Rejected
Pfizer Rule:   Rejected GSK Rule:   Rejected
Golden Triangle Rule:   Rejected BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.372 Fluc inhibitor:   0.619
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.619
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.449
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.001 Promiscuous compounds:   0.327

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.06 MDCK Permeability:   -4.808
Pgp-inhibitor:   0.99 Pgp-substrate:   0.997
PAMPA:   0.02
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.722
20% Bioavailability (F20%):   0.999 30% Bioavailability (F30%):   1.0
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.898
Plasma Protein Binding (PPB):   92.474% Volume Distribution (VD):   0.054
Fu: 7.41%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.797
OATP1B3 inhibitor:   0.544 BCRP inhibitor:   0.996
BSEP inhibitor:   0.851

ADMET: Metabolism

CYP1A2-inhibitor:   0.38 CYP1A2-substrate:   0.711
CYP2C19-inhibitor:   1.0 CYP2C19-substrate:   0.061
CYP2C9-inhibitor:   0.181 CYP2C9-substrate:   0.001
CYP2D6-inhibitor:   0.115 CYP2D6-substrate:   0.272
CYP3A4-inhibitor:   0.845 CYP3A4-substrate:   0.169
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.062
HLM stability:   0.922
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  8.083 Half-life (T1/2):  1.208

ADMET: Toxicity

hERG Blockers:  0.053 hERG Blockers (10um):  0.112
Human Hepatotoxicity (H-HT):  1.0 Drug-induced Liver Injury (DILI):  0.999
AMES Toxicity:  0.216 Rat Oral Acute Toxicity:  0.861
Maximum Recommended Daily Dose:  0.984 Skin Sensitization:  0.999
Carcinogencity:  0.341 Eye Corrosion:  0.0
Eye Irritation:  0.08 Respiratory Toxicity:  0.998
Drug-induced Neurotoxicity:  0.607 Ototoxicity:  0.971
Hematotoxicity:  0.362 Drug-induced Nephrotoxicity:  0.929
Genotoxicity:  1.0 RPMI-8226 Immunitoxicity:  0.006
A549 Cytotoxicity:  0.004 Hek293 Cytotoxicity:  0.076
BCF:   1.409
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   4.217
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   5.618
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   5.183
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO64868 Astragalus membranaceus + Penicillium sp. symbiont Species n.a. n.a. n.a. n.a. n.a. DOI[10.1007/s10600-018-2594-6]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[17616609]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[17929896]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[19113967]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[19159274]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[19256529]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. isolated from sediment collected using a hand held deep water sampling device at >33 m depth in Vanuatu 2003 PMID[20303767]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21667925]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21954885]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[22106303]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota stem bark of Melia azedarach n.a. n.a. PMID[22409377]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[23557488]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[23563483]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[7622436]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. Database[COCONUT]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO10538 Aspergillus fumigatus Species Aspergillaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT1794 Individual protein LXR-alpha Homo sapiens FC = 2.05 n.a. PMID[38334086]
NPT1794 Individual protein LXR-alpha Homo sapiens FC = 5.01 n.a. PMID[38334086]
NPT1794 Individual protein LXR-alpha Homo sapiens Activity n.a. n.a. n.a. PMID[38334086]
NPT1794 Individual protein LXR-alpha Homo sapiens Kd = 10.2 nM PMID[38334086]
NPT21727 Single protein CDGSH iron-sulfur domain-containing protein 1 Homo sapiens IC50 = 3387.0 nM PMID[27687671]
NPT21727 Single protein CDGSH iron-sulfur domain-containing protein 1 Homo sapiens Ki = 145.0 nM PMID[27687671]

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT83 Cell line MCF7 Homo sapiens Cell survival > 100.0 % PMID[11931609]
NPT83 Cell line MCF7 Homo sapiens Cell survival = 95.0 % PMID[11931609]
NPT306 Cell line PC-3 Homo sapiens Cell survival = 99.2 % PMID[11931609]
NPT306 Cell line PC-3 Homo sapiens Cell survival = 95.6 % PMID[11931609]
NPT83 Cell line MCF7 Homo sapiens Inhibition > 100.0 % DrugMatrix in vitro pharmacology data
NPT83 Cell line MCF7 Homo sapiens Inhibition = 95.0 % PMID[7143358]
NPT306 Cell line PC-3 Homo sapiens Inhibition = 99.2 % PMID[11754602]
NPT306 Cell line PC-3 Homo sapiens Inhibition = 95.6 % DOI[10.6019/CHEMBL1201861]
NPT404 Cell line CCRF-CEM Homo sapiens GI50 > 100000.0 nM PMID[17548494]
NPT111 Cell line K562 Homo sapiens GI50 = 2730.0 nM PMID[17844994]
NPT389 Cell line RPMI-8226 Homo sapiens GI50 = 37100.0 nM PMID[2292684]
NPT385 Cell line SR Homo sapiens GI50 = 5680.0 nM PMID[26090896]
NPT372 Cell line HOP-92 Homo sapiens GI50 = 21200.0 nM DrugMatrix in vivo data: Biochemistry
NPT394 Cell line EKVX Homo sapiens GI50 > 100000.0 nM DrugMatrix in vivo data: Biochemistry
NPT407 Cell line COLO 205 Homo sapiens GI50 > 100000.0 nM PMID[19349520]
NPT390 Cell line LOX IMVI Homo sapiens GI50 > 100000.0 nM PMID[19738026]
NPT377 Cell line OVCAR-3 Homo sapiens GI50 > 100000.0 nM PMID[11858756]
NPT458 Cell line IGROV-1 Homo sapiens GI50 = 90500.0 nM PMID[17350734]
NPT306 Cell line PC-3 Homo sapiens GI50 = 94000.0 nM DOI[10.6019/CHEMBL1201861]
NPT90 Cell line DU-145 Homo sapiens GI50 > 100000.0 nM DOI[10.6019/CHEMBL1201861]
NPT457 Cell line BT-549 Homo sapiens GI50 = 79700.0 nM PMID[23046382]
NPT83 Cell line MCF7 Homo sapiens GI50 > 100000.0 nM PMID[25725376]
NPT371 Cell line UO-31 Homo sapiens GI50 > 100000.0 nM PMID[9514009]
NPT111 Cell line K562 Homo sapiens IC50 = 41000.0 nM DrugMatrix in vitro pharmacology data
NPT65 Cell line HepG2 Homo sapiens Activity n.a. n.a. n.a. PMID[38334086]
NPT65 Cell line HepG2 Homo sapiens IC50 > 50000.0 nM PMID[38334086]
NPT28438 Unchecked Unchecked n.a. Activity n.a. n.a. n.a. PMID[38334086]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Inhibition = 80.1 % PMID[18321710]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. Inhibition = 79.4 % PMID[18321710]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 = 11300.0 nM PMID[18321710]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. GI50 > 100000.0 nM PMID[18321710]
NPT20529 Non-molecular NON-PROTEIN TARGET n.a. IC50 = 68000.0 nM PMID[18321710]
NPT2 Others Unspecified n.a. IC50 = 250000.0 nM PMID[19419803]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus Activity n.a. n.a. n.a. PMID[38334086]





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference
- Artemia salina LC50 = 44.8 ug.mL-1 PMID[18330977]

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC303658 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.7867 Intermediate Similarity NPC194740
0.7671 Intermediate Similarity NPC91179
0.525 Remote Similarity NPC17059

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC303658 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data